InhibrxInc Historical Income Statement

INBX Stock  USD 35.15  0.08  0.23%   
Historical analysis of InhibrxInc income statement accounts such as Tax Provision of 2.6 K or Depreciation And Amortization of 1.1 M can show how well InhibrxInc performed in making a profits. Evaluating InhibrxInc income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of InhibrxInc's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining InhibrxInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InhibrxInc is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.

About InhibrxInc Income Statement Analysis

InhibrxInc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to InhibrxInc shareholders. The income statement also shows InhibrxInc investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

InhibrxInc Income Statement Chart

InhibrxInc Income Statement is one of the three primary financial statements used for reporting InhibrxInc's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of InhibrxInc revenue and expense. InhibrxInc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, InhibrxInc's Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to rise to about 30.9 M in 2024, despite the fact that Net Loss is likely to grow to (124.2 M).

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts InhibrxInc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of InhibrxInc. It is also known as InhibrxInc overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from InhibrxInc's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into InhibrxInc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.At this time, InhibrxInc's Interest Expense is fairly stable compared to the past year. Selling General Administrative is likely to rise to about 30.9 M in 2024, despite the fact that Net Loss is likely to grow to (124.2 M).
 2021 2022 2023 2024 (projected)
Total Operating Expenses83.7M131.3M219.8M230.8M
Cost Of Revenue2.7M2.8M1.2M1.1M

InhibrxInc income statement Correlations

0.44-0.23-0.410.39-0.83-0.470.470.480.47-0.470.480.4-0.47-0.20.470.370.461.00.55-0.340.34
0.44-0.79-0.950.7-0.64-0.960.970.980.97-0.960.970.38-0.96-0.790.970.990.970.440.81-0.770.74
-0.23-0.790.8-0.430.540.75-0.76-0.82-0.760.75-0.76-0.20.761.0-0.77-0.84-0.77-0.23-0.780.46-0.41
-0.41-0.950.8-0.820.550.99-0.99-0.99-0.990.98-0.99-0.570.990.79-0.99-0.97-0.99-0.41-0.90.81-0.82
0.390.7-0.43-0.82-0.28-0.770.790.770.79-0.760.790.87-0.77-0.420.790.720.780.390.81-0.690.68
-0.83-0.640.540.55-0.280.6-0.6-0.64-0.60.6-0.6-0.240.60.52-0.6-0.59-0.6-0.83-0.670.36-0.35
-0.47-0.960.750.99-0.770.6-1.0-0.98-1.01.0-1.0-0.511.00.75-1.0-0.97-1.0-0.47-0.860.86-0.86
0.470.97-0.76-0.990.79-0.6-1.00.991.0-1.01.00.53-1.0-0.751.00.971.00.470.87-0.870.83
0.480.98-0.82-0.990.77-0.64-0.980.990.99-0.980.990.5-0.98-0.820.990.990.990.480.9-0.790.76
0.470.97-0.76-0.990.79-0.6-1.01.00.99-1.01.00.53-1.0-0.751.00.971.00.470.87-0.870.83
-0.47-0.960.750.98-0.760.61.0-1.0-0.98-1.0-1.0-0.491.00.74-1.0-0.97-1.0-0.47-0.850.86-0.86
0.480.97-0.76-0.990.79-0.6-1.01.00.991.0-1.00.53-1.0-0.751.00.971.00.480.87-0.870.83
0.40.38-0.2-0.570.87-0.24-0.510.530.50.53-0.490.53-0.51-0.190.520.410.510.40.74-0.480.47
-0.47-0.960.760.99-0.770.61.0-1.0-0.98-1.01.0-1.0-0.510.75-1.0-0.97-1.0-0.47-0.860.86-0.86
-0.2-0.791.00.79-0.420.520.75-0.75-0.82-0.750.74-0.75-0.190.75-0.76-0.83-0.77-0.2-0.770.46-0.41
0.470.97-0.77-0.990.79-0.6-1.01.00.991.0-1.01.00.52-1.0-0.760.981.00.470.87-0.860.83
0.370.99-0.84-0.970.72-0.59-0.970.970.990.97-0.970.970.41-0.97-0.830.980.980.370.84-0.770.74
0.460.97-0.77-0.990.78-0.6-1.01.00.991.0-1.01.00.51-1.0-0.771.00.980.460.87-0.860.82
1.00.44-0.23-0.410.39-0.83-0.470.470.480.47-0.470.480.4-0.47-0.20.470.370.460.55-0.340.34
0.550.81-0.78-0.90.81-0.67-0.860.870.90.87-0.850.870.74-0.86-0.770.870.840.870.55-0.630.61
-0.34-0.770.460.81-0.690.360.86-0.87-0.79-0.870.86-0.87-0.480.860.46-0.86-0.77-0.86-0.34-0.63-0.81
0.340.74-0.41-0.820.68-0.35-0.860.830.760.83-0.860.830.47-0.86-0.410.830.740.820.340.61-0.81
Click cells to compare fundamentals

InhibrxInc Account Relationship Matchups

InhibrxInc income statement Accounts

201920202021202220232024 (projected)
Interest Expense5.7M10.8M5.2M16.1M31.8M33.4M
Net Income Applicable To Common Shares(51.4M)(76.1M)(81.8M)(145.2M)(130.7M)(124.2M)
Tax Provision96K898K3K2K2.7K2.6K
Net Interest Income(5.7M)(10.8M)(5.2M)(16.1M)(19.9M)(18.9M)
Depreciation And Amortization1.1M1.0M1.2M1.2M1.2M1.1M
Selling General Administrative9.0M6.8M12.4M21.1M29.4M30.9M
Total Revenue9.1M12.8M7.1M2.2M1.8M1.7M
Gross Profit(38.8M)12.8M7.1M2.2M609K639.5K
Other Operating Expenses52.8M80.3M83.7M131.3M221.0M232.1M
Operating Income(43.7M)(67.4M)(76.6M)(129.1M)(219.2M)(208.3M)
Net Income From Continuing Ops(51.4M)(76.1M)(81.8M)(145.2M)(188.7M)(179.2M)
Ebit(43.7M)(67.4M)(76.6M)(129.1M)(219.2M)(208.3M)
Research Development47.9M73.5M71.4M110.2M190.6M200.2M
Ebitda(42.6M)(66.4M)(75.4M)(127.9M)(218.0M)(207.1M)
Cost Of Revenue47.9M73.5M2.7M2.8M1.2M1.1M
Total Operating Expenses52.8M80.3M83.7M131.3M219.8M230.8M
Reconciled Depreciation676K1.2M1.0M1.2M1.2M1.1M
Income Before Tax(50.5M)(75.6M)(81.8M)(145.2M)(239.7M)(227.7M)
Total Other Income Expense Net(6.8M)(8.2M)(5.2M)(16.1M)(20.5M)(19.5M)
Net Income(51.4M)(75.6M)(81.8M)(145.2M)(241.4M)(229.3M)
Income Tax Expense96K898K3K2K2.7K2.6K
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InhibrxInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InhibrxInc's short interest history, or implied volatility extrapolated from InhibrxInc options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether InhibrxInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of InhibrxInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inhibrxinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inhibrxinc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.
Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for InhibrxInc Stock analysis

When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.12)
Revenue Per Share
0.038
Quarterly Revenue Growth
4.964
Return On Assets
(0.46)
Return On Equity
(4.75)
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.